Skip to Content

  • Search

View Additional Section Content

CHANT Trial - A Double-Blind, Randomized, Placebo-controlled, Parallel Group, Multicenter, Phase IIb Study to Assess the Safety and Tolerability of 72 Hours Intravenous NXY-059 in Patients with Acute Intracerebral Hemorrhage (ICH)

Principal Investigator(s)
B. Franklin Diamond, M.D.

Clinical Trial Categories

  • Stroke Research
Contact
Debi Murphy at 215-481-3627

Location

  • The Stroke Center at Abington Memorial Hospital

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details